Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild and Moderate Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01397578
What this trial is testing

Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 91
Testing effectiveness (Phase 2)Study completedNCT00265148
What this trial is testing

Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 80
Testing effectiveness (Phase 2)Ended earlyNCT01712074
What this trial is testing

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Who this might be right for
Alzheimer's Disease
Pfizer 186
Large-scale testing (Phase 3)Study completedNCT01561053
What this trial is testing

Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 347
Testing effectiveness (Phase 2)Study completedNCT00357357
What this trial is testing

European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Hunter-Fleming Ltd 40
Early research (Phase 1)Study completedNCT02910739
What this trial is testing

An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 16
Testing effectiveness (Phase 2)Study completedNCT01137526
What this trial is testing

Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 267
Testing effectiveness (Phase 2)UnknownNCT00154635
What this trial is testing

Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Ended earlyNCT00960531
What this trial is testing

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 160
Large-scale testing (Phase 3)Study completedNCT01689246
What this trial is testing

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 891
Early research (Phase 1)Study completedNCT00633841
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Early research (Phase 1)Study completedNCT00675090
What this trial is testing

Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 28
Large-scale testing (Phase 3)Study completedNCT00818662
What this trial is testing

Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease

Who this might be right for
Alzheimer´s Disease
Baxalta now part of Shire 390
Large-scale testing (Phase 3)Ended earlyNCT01969123
What this trial is testing

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
FORUM Pharmaceuticals Inc 474
Testing effectiveness (Phase 2)Study completedNCT00940589
What this trial is testing

Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor

Who this might be right for
Alzheimer's DiseaseSleep Disorder
Neurim Pharmaceuticals Ltd. 73
Early research (Phase 1)Study completedNCT04715750
What this trial is testing

Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Who this might be right for
Alzheimer DiseaseProgressive Supranuclear Palsy
Life Molecular Imaging GmbH 10
Early research (Phase 1)Ended earlyNCT02220738
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
AbbVie 19
Large-scale testing (Phase 3)Ended earlyNCT01969136
What this trial is testing

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
FORUM Pharmaceuticals Inc 403
Testing effectiveness (Phase 2)Looking for participantsNCT07457125
What this trial is testing

The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Xuanwu Hospital, Beijing 33
Large-scale testing (Phase 3)WithdrawnNCT01211782
What this trial is testing

AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)

Who this might be right for
Alzheimer's Disease
Cerecin
Next Page